MARKSANS
MARKSANS PHARMA LIMITED

169.47 -3.54 (-2.09%)

Stop-loss on the minds of MARKSANS investors as it ranked worse than it's peers

20 Jan, 20265 min read

MARKSANS ranked worse than it's peers today. On a longer term basis, investors in MARKSANS PHARMA LIMITED made +0.03% per day. Tuesday's performance of -2.09% was a underperformance compared to it's daily average.

Want to improve your Portfolio's performance?
Spotalpha's Portfolio optimizer is all you need to improve your returns and reduce your risk.
Optimize Portfolio NOW
Read analysis
Following
Symbol Price {{retType}} | Tr.
{{detail.symbol}} {{detail.close}} {{detail.priceChange}}  {{detail.pctChange}}%  {{detail.name}} {{detail.trend}}